# Telemonitoring met farmaceutische begeleiding verlaagt bloeddruk beter dan reguliere zorg

*geplaatst 2026-10-09 · Hypertensie · Journal of the American College of Clinical Pharmacy : JACCP · doi 10.1002/jac5.70296 · https://hartvaat.nl/2026/10/01/telemonitoring-met-farmaceutische-begeleiding-verlaagt-bloeddruk-beter-dan-regul/*

Een retrospectieve cohortstudie onder patiënten met ongecontroleerde hypertensie toont aan dat een telemonitoringprogramma met dagelijkse monitoring en farmaceutische medicatiemanagement leidt tot een significanter bloeddrukdaling dan reguliere poliklinische zorg. Na propensity score-matching (n=201 paren) daalde de systolische bloeddruk met 14,9 mmHg versus 8,2 mmHg (p<0,001) en de diastolische met 5,9 versus 2,2 mmHg (p=0,002). Deze bevindingen ondersteunen de integratie van gestructureerde telehealth-modellen en apothekers in de hypertensiebestrijding, mits patiëntbetrokkenheid en vergoeding structureel worden opgelost.

## English: Pharmacist-Led Remote Patient Monitoring for Hypertension: A Retrospective Evaluation of Blood Pressure Outcomes.

A retrospective propensity-matched cohort study evaluated a pharmacist-led remote patient monitoring program for uncontrolled hypertension compared to usual in-clinic care. Among 201 matched pairs, the intervention group achieved significantly greater reductions in systolic blood pressure (-14.9 vs -8.2 mmHg; p<0,001) and diastolic blood pressure (-5.9 vs -2.2 mmHg; p=0,002). The findings support integrating structured telehealth and pharmacist-led medication management into routine hypertension care, though long-term sustainability will depend on patient engagement and reimbursement frameworks.

## Abstract (original, from the publication)

BACKGROUND: Uncontrolled hypertension remains a leading risk factor for cardiovascular disease, particularly in rural and medically underserved populations. Remote patient monitoring (RPM) and protocol-driven care models have emerged as promising strategies to improve blood pressure (BP) control. This study evaluated a pharmacist-led RPM program for patients with uncontrolled hypertension integrated into routine clinical practice. METHODS: A retrospective chart review was conducted among adults with uncontrolled hypertension enrolled in an RPM program at a large academic medical center between 2018 and 2022. The program incorporated Bluetooth-enabled BP monitors, daily registered nurse (RN) monitoring, and pharmacist-led medication management guided by a standardized treatment protocol. Propensity score matching was used to compare clinic BP outcomes with a control group receiving usual in-clinic care. RESULTS: Of 471 patients who actively participated, 209 (44.4%) completed the program and were included in the primary analysis. Propensity score matching identified 201 matched pairs with balanced baseline characteristics. Compared with controls, RPM participants achieved greater reductions in systolic BP (-14.9 vs. -8.2 mmHg; p < 0.001) and diastolic BP (-5.9 vs. -2.2 mmHg; p = 0.002). CONCLUSION: A pharmacist-led, protocol-driven RPM program was associated with greater reductions in BP compared with those receiving in-clinic care alone. These findings support the integration of pharmacists and structured treatment algorithms in telehealth-enabled hypertension management. Improving patient engagement and addressing reimbursement challenges remain essential for long-term program sustainability.

Auteurs: Carly Brown, Saurabh Chandra, Donald Clark

---
Bron: Journal of the American College of Clinical Pharmacy : JACCP, https://doi.org/10.1002/jac5.70296. Bijgewerkt 2026-10-02T01:16:00Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.